Correlation of Selective Modifications to a 2‘,5‘-Oligoadenylate−3‘,5‘-Deoxyribonucleotide Antisense Chimera with Affinity for the Target Nucleic Acid and with Ability To Activate RNase L
- 1 April 1997
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 40 (8) , 1195-1200
- https://doi.org/10.1021/jm960748l
Abstract
The use of an antisense oligonucleotide to address a specific targeted RNA sequence and subsequent localized activation of the 2-5A-dependent RNase (RNase L) to effect selective RNA degradation is a new approach to the control of gene expression called 2-5A-antisense. The previously reported biological activity of the 2-5A:AS chimeric oligonucleotide [p5‘(A2‘p)3A-antiPKR1], directed against nucleotides 55−73 of the coding sequence of the PKR mRNA, has been used as a point of reference to examine the effect of introducing mismatches into the chimeric oligonucleotide, altering the chain length of the antisense domain of the chimeras, removal of the 5‘-monophosphate moiety, shortening the 2‘,5‘-oligoadenylate domain, and substitution of 3‘,5‘-linked 2‘-deoxyadenosine nucleotides for the 2-5A domain. The general formula for the novel chimeric oligonucleotides is p5‘(A2‘p)3A2‘p(CH2)4p(CH2)4p(5‘N3‘p)mN, where N is any nucleoside and m is any integer. When the biological activity of these new chimeric oligonucleotides was compared to that of the parent chimera, 2-5A-aPKR, for their ability to effect target PKR RNA cleavage in a cell-free and in an intact cell assay, it was determined that there was a close correlation between the activity of 2-5A-antisense chimeras and their affinity (Tm) for a targeted nucleic acid. In addition, there was also a close correlation between activity of the 2-5A-antisense chimeras and their ability to activate the 2-5A-dependent RNase L.Keywords
This publication has 12 references indexed in Scilit:
- Synthesis and Characterization of Composite Nucleic Acids Containing 2‵,5‵-Oligoriboadenylate Linked to Antisense DNAAntisense and Nucleic Acid Drug Development, 1996
- 2′,5′-Oligoadenylate Antisense Chimeras for Targeted Ablation of RNAPublished by American Chemical Society (ACS) ,1994
- Synthesis of a 5′-thiophosphate analogue of 2-5A, a phosphatase resistant activator of the 2-5A-dependent ribonucleaseBioorganic & Medicinal Chemistry Letters, 1994
- Blockage of NF-κB Signaling by Selective Ablation of an mRNA target by 2-5A Antisense ChimerasScience, 1994
- 2',5'-Oligoadenylate:antisense chimeras. Synthesis and propertiesBioconjugate Chemistry, 1993
- Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?Science, 1993
- Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferonCell, 1990
- [23] Nuclease digestion: A method for mapping intronsPublished by Elsevier ,1989
- Predicting DNA duplex stability from the base sequence.Proceedings of the National Academy of Sciences, 1986
- Oligonucleotide structural parameters that influence binding of 5'-O-triphosphoadenylyl-(2' .fwdarw. 5')-adenylyl-(2' .fwdarw. 5')-adenosine to the 5'-O-triphosphoadenylyl-(2' .fwdarw. 5')-adenylyl-(2' .fwdarw. 5')-adenosine dependent endoribonuclease: chain length, phosphorylation state, and heterocyclic baseJournal of Medicinal Chemistry, 1984